Apimeds Pharmaceuticals Us logo

Apimeds Pharmaceuticals Us Share Price (NYSE: APUS)

$1.82

-0.04

(-2.15%)

Last updated on

Check the interactive Apimeds Pharmaceuticals Us Stock chart to analyse performance

Apimeds Pharmaceuticals Us stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$1.82
    Today's High:$1.91

    Day's Volatility :4.71%

  • 52 Weeks Low:$1.37
    52 Weeks High:$4.00

    52 Weeks Volatility :65.75%

Apimeds Pharmaceuticals Us Stock Returns

PeriodApimeds Pharmaceuticals UsIndex (Russel 2000)
3 Months
1.39%
0.0%
6 Months
-17.05%
0.0%
1 Year
-17.05%
0.0%
3 Years
-17.05%
-4.7%

Apimeds Pharmaceuticals Us Key Stats

Check Apimeds Pharmaceuticals Us key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$1.86
Open
$1.89
Today's High
$1.91
Today's Low
$1.82
Market Capitalization
$24.3M
Today's Volume
$37.0K
52 Week High
$4.0
52 Week Low
$1.37
Revenue TTM
$0.0
Earnings Per Share (EPS)
$-0.13
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
0.0%

Stock Returns calculator for Apimeds Pharmaceuticals Us Stock including INR - Dollar returns

The Apimeds Pharmaceuticals Us stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Apimeds Pharmaceuticals Us investment value today

Current value as on today

₹88,011

Returns

₹11,989

(-11.99%)

Returns from Apimeds Pharmaceuticals Us Stock

₹17,273 (-17.27%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Apimeds Pharmaceuticals Us Stock

67%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Apimeds Pharmaceuticals Us Stock from India on INDmoney has increased by 67% in the last 30 days, reflecting an upward trend in search activity.

Analyst Recommendation on Apimeds Pharmaceuticals Us Stock

Rating
Trend

Apimeds Pharmaceuticals Us Stock Insights

  • Price Movement

    In the last 7 days, APUS stock has moved down by -17.0%

Apimeds Pharmaceuticals Us Technicals Summary

Sell

Neutral

Buy

Apimeds Pharmaceuticals Us is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Apimeds Pharmaceuticals Us Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Apimeds Pharmaceuticals Us logo
4.89%
-17.05%
-17.05%
-17.05%
-17.05%
Haleon Plc Spon Ads logo
1.5%
-7.33%
-3.49%
69.05%
32.32%
United Therapeutics Corporation logo
3.57%
-1.69%
-13.51%
34.83%
71.41%
Zoetis Inc. logo
6.13%
-8.28%
-14.8%
-1.88%
-3.48%
Neurocrine Biosciences Inc. logo
8.29%
21.94%
11.59%
32.16%
20.59%

About Apimeds Pharmaceuticals Us

Apimeds Pharmaceuticals US, Inc. operates as a clinical stage biopharmaceutical company in the United States. It researches, develops, manufactures, commercializes, and sells Apitox, a purified, pharmaceutical grade venom of the Apis mellifera, or honeybee for the treatment of inflammation and pain management symptoms associated with osteoarthritis and multiple sclerosis. The company has a strategic alliance with University of Alabama for the development of ai² future labs program. The company was incorporated in 2020 and is based in Matawan, New Jersey.
Organization
Apimeds Pharmaceuticals Us
Employees
2
CEO
Mr. Erik C. Emerson
Industry
Miscellaneous

Key Management of Apimeds Pharmaceuticals Us

NameTitle
Dr. Christopher M. H. Kim M.D.
Chief Medical Officer & Chairman
Mr. Erik C. Emerson
CEO & Director
Mr. Erick J. Frim
Chief Financial Officer
Mr. Brian Peters
Head of Proprietary AI Division
Dr. Susan M. Kramer Dr. P.H.
Senior Vice President of Development

Important FAQs about investing in APUS Stock from India :

What is Apimeds Pharmaceuticals Us share price today?

Apimeds Pharmaceuticals Us share price today is $1.82 as on at the close of the market. Apimeds Pharmaceuticals Us share today touched a day high of $1.91 and a low of $1.82.

What is the 52 week high and 52 week low for Apimeds Pharmaceuticals Us share?

Apimeds Pharmaceuticals Us share touched a 52 week high of $4.00 and a 52 week low of $1.37. Apimeds Pharmaceuticals Us stock price today i.e. is closed at $1.82, lower by 54.5% versus the 52 week high.

How to invest in Apimeds Pharmaceuticals Us Stock (APUS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Apimeds Pharmaceuticals Us on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Apimeds Pharmaceuticals Us Shares that will get you 0.8242 shares as per Apimeds Pharmaceuticals Us share price of $1.82 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Apimeds Pharmaceuticals Us Stock (APUS) from India?

Indian investors can start investing in Apimeds Pharmaceuticals Us (APUS) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Apimeds Pharmaceuticals Us stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Apimeds Pharmaceuticals Us share’s latest price of $1.82 as on August 30, 2025 at 1:29 am IST, you will get 5.4945 shares of Apimeds Pharmaceuticals Us. Learn more about fractional shares .

What are the returns that Apimeds Pharmaceuticals Us has given to Indian investors in the last 5 years?

Apimeds Pharmaceuticals Us stock has given -17.05% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?